3 ms·
except it doesn't in this case. Manufacturers keep the price artificially high by continually patenting more and more esoteric parts of the manufacturing of thi
by nappy-doo 7y ago
except it doesn't in this case. Manufacturers keep the price artificially high by continually patenting more and more esoteric parts of the manufacturing of this drug. They then cross license the patents to each other, preventing any third party from joining the marketplace.
Insulin is NOT rocket science, and it's necessary for some people to live. It's almost as simple to make as beer. It is unreasonable that people don't have access to such a simple life saving drug.
Fuck the pharma companies. Fuck the patent system for keeping it this way. Congratulate the legislature who is tackling this problem.
- cjfd 7y agoYou know, dropping f bombs is not a very mature way to engage in discussion. I agree, though, that it should also become harder to get patents. If a useful invention depends on more than one or, at most, two patents the patents mainly serve as friction to innovation. A corrollary of this is that software patents should not exist. Perhaps there could also be a process where it is asserted that a medicine can only depend on one patent. Whenever it depends on more than one it should be adjudicated which of them is the innovative one and the other ones should not apply. This will solve the cross licensing problem that you notice.